Suppr超能文献

Notch 信号蛋白:癌症治疗的合法靶点。

Notch signaling proteins: legitimate targets for cancer therapy.

机构信息

Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 9374 Scott Hall, 540 E Canfield, Detroit, MI 48201, USA.

出版信息

Curr Protein Pept Sci. 2010 Sep;11(6):398-408. doi: 10.2174/138920310791824039.

Abstract

Proteins and small peptides (growth factors and hormones) are key molecules in maintaining cellular homeostasis. To that end, Notch signaling pathway proteins are known to play critical roles in maintaining the balance between cell proliferation, differentiation and apoptosis, and thus it has been suggested that Notch may be responsible for the development and progression of human malignancies. Therefore, the Notch signaling pathway proteins may present novel therapeutic targets, which could have promising therapeutic impact on eradicating human malignancies. This review describes the role of Notch signaling pathway proteins in cancer and how its deregulation is involved in tumor development and progression leading to metastasis and the ultimate demise of patients diagnosed with cancer. Further, we summarize the role of several Notch inhibitors especially "natural agents" that could represent novel therapeutic strategies targeting Notch signaling toward better treatment outcome of patients diagnosed with cancer.

摘要

蛋白质和小肽(生长因子和激素)是维持细胞内稳态的关键分子。为此,已知 Notch 信号通路蛋白在维持细胞增殖、分化和凋亡之间的平衡方面发挥着关键作用,因此有人认为 Notch 可能与人类恶性肿瘤的发生和发展有关。因此, Notch 信号通路蛋白可能是新的治疗靶点,这可能对消除人类恶性肿瘤具有潜在的治疗意义。本文综述了 Notch 信号通路蛋白在癌症中的作用,以及其失调如何参与肿瘤的发生和发展,导致转移,并最终导致被诊断患有癌症的患者死亡。此外,我们总结了几种 Notch 抑制剂的作用,特别是“天然药物”,它们可能代表针对 Notch 信号的新型治疗策略,以改善被诊断患有癌症的患者的治疗效果。

相似文献

1
Notch signaling proteins: legitimate targets for cancer therapy.
Curr Protein Pept Sci. 2010 Sep;11(6):398-408. doi: 10.2174/138920310791824039.
2
Regulation of EMT by Notch signaling pathway in tumor progression.
Curr Cancer Drug Targets. 2013 Nov;13(9):957-62. doi: 10.2174/15680096113136660101.
5
Study Deciphering the Crucial Involvement of Notch Signaling Pathway in Human Cancers.
Endocr Metab Immune Disord Drug Targets. 2024;24(11):1241-1253. doi: 10.2174/0118715303261691231107113548.
6
Notch-associated microRNAs in cancer.
Curr Drug Targets. 2013 Sep;14(10):1157-66. doi: 10.2174/13894501113149990188.
7
Molecular pathways: translational and therapeutic implications of the Notch signaling pathway in cancer.
Clin Cancer Res. 2015 Mar 1;21(5):955-61. doi: 10.1158/1078-0432.CCR-14-0809. Epub 2014 Nov 11.
8
Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
Drug Res (Stuttg). 2016 Nov;66(11):571-579. doi: 10.1055/s-0042-111821. Epub 2016 Oct 4.
9
Notch Signaling in Cancer: Rationale and Strategies for Targeting.
Curr Cancer Drug Targets. 2015;15(5):364-74. doi: 10.2174/156800961505150710113353.
10
Notch signaling: emerging molecular targets for cancer therapy.
Biochem Pharmacol. 2010 Sep 1;80(5):690-701. doi: 10.1016/j.bcp.2010.03.026. Epub 2010 Mar 31.

引用本文的文献

1
The role of notch signaling pathway in cancer: mechanistic insights, therapeutic potential, and clinical progress.
Front Immunol. 2025 Jun 24;16:1567524. doi: 10.3389/fimmu.2025.1567524. eCollection 2025.
2
Molecular perspectives on systemic priming and concomitant immunity in colorectal carcinoma.
J Egypt Natl Canc Inst. 2024 Mar 11;36(1):7. doi: 10.1186/s43046-024-00211-9.
4
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development.
Mol Cancer Ther. 2023 Jan 3;22(1):3-11. doi: 10.1158/1535-7163.MCT-22-0243.
8
RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption.
Aging (Albany NY). 2021 May 2;13(9):12526-12536. doi: 10.18632/aging.202926.
9
The clinical significance of Notch1 immunoexpression in Caucasian patients with colorectal adenocarcinoma.
Prz Gastroenterol. 2020;15(4):314-322. doi: 10.5114/pg.2020.101560. Epub 2020 Dec 10.
10
Emerging role of tumor cell plasticity in modifying therapeutic response.
Signal Transduct Target Ther. 2020 Oct 7;5(1):228. doi: 10.1038/s41392-020-00313-5.

本文引用的文献

1
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Cancer Res. 2009 Oct 1;69(19):7569-76. doi: 10.1158/0008-5472.CAN-09-0529. Epub 2009 Sep 22.
3
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
PLoS One. 2009 Aug 28;4(8):e6816. doi: 10.1371/journal.pone.0006816.
5
The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2.
Cancer Res. 2009 Jun 15;69(12):5039-48. doi: 10.1158/0008-5472.CAN-08-4021. Epub 2009 Jun 2.
6
Cancer statistics, 2009.
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
7
Notch signaling: the core pathway and its posttranslational regulation.
Dev Cell. 2009 May;16(5):633-47. doi: 10.1016/j.devcel.2009.03.010.
9
Expression and clinical significance of Notch receptors in human renal cell carcinoma.
Pathology. 2009;41(4):335-41. doi: 10.1080/00313020902885003.
10
The canonical Notch signaling pathway: unfolding the activation mechanism.
Cell. 2009 Apr 17;137(2):216-33. doi: 10.1016/j.cell.2009.03.045.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验